These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience. Briere TM; McAleer MF; Levy LB; Yang JN Radiat Oncol; 2017 May; 12(1):79. PubMed ID: 28464840 [TBL] [Abstract][Full Text] [Related]
4. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687 [TBL] [Abstract][Full Text] [Related]
5. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer. Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467 [No Abstract] [Full Text] [Related]
6. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique. Lu JY; Wu LL; Zhang JY; Zheng J; Cheung ML; Ma CC; Xie LX; Huang BT Br J Radiol; 2015 Feb; 88(1046):20140654. PubMed ID: 25494885 [TBL] [Abstract][Full Text] [Related]
7. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma. Sakanaka K; Mizowaki T; Hiraoka M Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515 [TBL] [Abstract][Full Text] [Related]
8. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study. Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376 [TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT. Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999 [TBL] [Abstract][Full Text] [Related]
10. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors. Hein PA; Gladstone DJ; Bellerive MR; Hug EB Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816 [TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy. Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733 [TBL] [Abstract][Full Text] [Related]
12. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application. Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396 [TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826 [TBL] [Abstract][Full Text] [Related]
14. Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site. Chatterjee A; Serban M; Abdulkarim B; Panet-Raymond V; Souhami L; Shenouda G; Sabri S; Jean-Claude B; Seuntjens J Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):1021-1028. PubMed ID: 28870791 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans. Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079 [TBL] [Abstract][Full Text] [Related]
16. Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning. Wu B; Ricchetti F; Sanguineti G; Kazhdan M; Simari P; Jacques R; Taylor R; McNutt T Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1241-7. PubMed ID: 20800382 [TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Hermanto U; Frija EK; Lii MJ; Chang EL; Mahajan A; Woo SY Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1135-44. PubMed ID: 17208388 [TBL] [Abstract][Full Text] [Related]
18. Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT. Al-Wassia RK; Ghassal NM; Naga A; Awad NA; Bahadur YA; Constantinescu C J Pediatr Hematol Oncol; 2015 Oct; 37(7):e405-11. PubMed ID: 26334433 [TBL] [Abstract][Full Text] [Related]
19. Integral dose delivered to normal brain with conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy IMRT during partial brain radiotherapy for high-grade gliomas with and without selective sparing of the hippocampus, limbic circuit and neural stem cell compartment. Marsh JC; Ziel GE; Diaz AZ; Wendt JA; Gobole R; Turian JV J Med Imaging Radiat Oncol; 2013 Jun; 57(3):378-83. PubMed ID: 23721150 [TBL] [Abstract][Full Text] [Related]
20. Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. Buglione M; Spiazzi L; Saiani F; Costa L; Shehi B; Lazzari B; Uccelli C; Pasinetti N; Borghetti P; Triggiani L; Donadoni L; Pedretti S; Magrini SM; Tumori; 2014; 100(3):272-7. PubMed ID: 25076237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]